开门红！中国资产大涨，逾千只股票ETF同频上涨

Core Viewpoint - The A-share market experienced a strong start in 2026, with the Shanghai Composite Index returning to 4000 points, driven by significant gains in technology sectors such as brain-computer interfaces, semiconductors, and pharmaceuticals [1][2] Market Performance - On January 5, 2026, the A-share market saw the Shanghai Composite Index rise over 2%, with the ChiNext Index and the Sci-Tech Innovation Index also showing strong performance [2] - The brain-computer interface index recorded nearly a 10% increase, while medical device and memory chip indices rose over 6% [2] - More than 1000 stock ETFs rose in tandem, with over 90% of all stock ETFs experiencing gains, particularly in the semiconductor and pharmaceutical sectors [2][4] ETF Trends - 35 ETFs related to semiconductors and pharmaceuticals saw gains exceeding 5%, with some medical device ETFs rising over 6% [2] - The top-performing ETF was the China-Korea Semiconductor ETF, which increased by 8.46% [3] - Cross-border ETFs also performed well, with over 90% of 185 ETFs rising, particularly those tracking the Hong Kong medical and pharmaceutical indices [3] Fund Flows and Investment Trends - In 2025, the total net inflow into ETFs exceeded 1.16 trillion yuan, with over 620 billion yuan directed towards industry-themed ETFs, particularly in AI and innovative pharmaceuticals [6] - The Hong Kong market saw significant inflows, with over 250 billion yuan into ETFs, especially those related to the Hang Seng Technology Index and medical sectors [6] Future Outlook - Analysts suggest that 2026 will focus on embracing technology growth and upstream cycles, with expectations of a slow bull market driven by stable growth policies and improving corporate earnings [7][8] - Key sectors for investment include renewable energy, chemicals, construction materials, and innovative pharmaceuticals, with a particular emphasis on AI applications and semiconductor advancements [8]